How is teriparatide administered to clients?

Teriparatide is administered subcutaneously, which means it is injected just under the skin. This method of administration is significant because it allows for the proper absorption of the medication into the bloodstream, enabling effective pharmacological action. Teriparatide is a recombinant form of parathyroid hormone and is primarily used in the treatment of osteoporosis to stimulate bone formation.

The subcutaneous route is selected for teriparatide because it is an effective way to maintain stable drug levels and provide sustained therapeutic effects. By using this method, patients can easily self-administer the injection, which promotes adherence to the treatment regimen. In contrast to other routes such as intravenous or intramuscular, subcutaneous administration is less invasive and typically involves fewer complications or technical requirements, making it a practical choice for long-term treatment.